MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

84.15 +4.43 (+5.56%)
Official Closing Price Updated: 7:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,816,701
Open 82.50
Bid (Size) 80.00 (100)
Ask (Size) 84.50 (100)
Prev. Close 79.72
Today's Range 82.12 - 84.74
52wk Range 72.30 - 87.89
Shares Outstanding 580,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗
Via Chartmill
Edwards Lifesciences Corp (NYSE:EW) Shares Surge After Q1 Earnings Beat and Raised Guidance ↗
Via Chartmill
Topics Earnings

Performance

YTD
-1.4%
-1.4%
1 Month
+2.5%
+2.5%
3 Month
-0.1%
-0.1%
6 Month
+4.1%
+4.1%
1 Year
+10.7%
+10.7%

More News

Read More
News headline image
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
From USA News Group
Via GlobeNewswire
Edwards Lifesciences Corp (NYSE:EW) Reports Mixed Q4 Results, Misses EPS Estimates ↗
Via Chartmill
News headline image
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Topics Lawsuit
News headline image
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
Via Finterra
Topics Economy Lawsuit Product Recall
News headline image
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
Via The Motley Fool
News headline image
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗
Via The Motley Fool
Friday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
Via MarketMinute
News headline image
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
From Edwards Lifesciences Corporation
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
The Return of the Mega-Deal: How 2026’s Regulatory Pragmatism is Reshaping Corporate America
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗
Via MarketBeat
News headline image
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
Edwards Lifesciences (EW) Earnings Transcript ↗
Via The Motley Fool
News headline image
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
Via MarketMinute
Topics Supply Chain

Frequently Asked Questions

Is Edwards Lifesciences publicly traded?
Yes, Edwards Lifesciences is publicly traded.
What exchange does Edwards Lifesciences trade on?
Edwards Lifesciences trades on the New York Stock Exchange
What is the ticker symbol for Edwards Lifesciences?
The ticker symbol for Edwards Lifesciences is EW on the New York Stock Exchange
What is the current price of Edwards Lifesciences?
The current price of Edwards Lifesciences is 84.15
When was Edwards Lifesciences last traded?
The last trade of Edwards Lifesciences was at 04/24/26 07:00 PM ET
What is the market capitalization of Edwards Lifesciences?
The market capitalization of Edwards Lifesciences is 48.87B
How many shares of Edwards Lifesciences are outstanding?
Edwards Lifesciences has 49B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story